173 related articles for article (PubMed ID: 29376135)
1. Using Collaborative Simulation Modeling to Develop a Web-Based Tool to Support Policy-Level Decision Making About Breast Cancer Screening Initiation Age.
Burnside ES; Lee SJ; Bennette C; Near AM; Alagoz O; Huang H; van den Broek JJ; Kim JY; Ergun MA; van Ravesteyn NT; Stout NK; de Koning HJ; Mandelblatt JS
MDM Policy Pract; 2017 Jul; 2(2):. PubMed ID: 29376135
[TBL] [Abstract][Full Text] [Related]
2. Collaborative Modeling of the Benefits and Harms Associated With Different U.S. Breast Cancer Screening Strategies.
Mandelblatt JS; Stout NK; Schechter CB; van den Broek JJ; Miglioretti DL; Krapcho M; Trentham-Dietz A; Munoz D; Lee SJ; Berry DA; van Ravesteyn NT; Alagoz O; Kerlikowske K; Tosteson AN; Near AM; Hoeffken A; Chang Y; Heijnsdijk EA; Chisholm G; Huang X; Huang H; Ergun MA; Gangnon R; Sprague BL; Plevritis S; Feuer E; de Koning HJ; Cronin KA
Ann Intern Med; 2016 Feb; 164(4):215-25. PubMed ID: 26756606
[TBL] [Abstract][Full Text] [Related]
3. Tailoring Breast Cancer Screening Intervals by Breast Density and Risk for Women Aged 50 Years or Older: Collaborative Modeling of Screening Outcomes.
Trentham-Dietz A; Kerlikowske K; Stout NK; Miglioretti DL; Schechter CB; Ergun MA; van den Broek JJ; Alagoz O; Sprague BL; van Ravesteyn NT; Near AM; Gangnon RE; Hampton JM; Chandler Y; de Koning HJ; Mandelblatt JS; Tosteson AN;
Ann Intern Med; 2016 Nov; 165(10):700-712. PubMed ID: 27548583
[TBL] [Abstract][Full Text] [Related]
4. Benefits and Harms of Mammography Screening for Women With Down Syndrome: a Collaborative Modeling Study.
Alagoz O; Hajjar A; Chootipongchaivat S; van Ravesteyn NT; Yeh JM; Ergun MA; de Koning HJ; Chicoine B; Martin B
J Gen Intern Med; 2019 Nov; 34(11):2374-2381. PubMed ID: 31385214
[TBL] [Abstract][Full Text] [Related]
5. Screening mammography for women aged 40 to 49 years at average risk for breast cancer: an evidence-based analysis.
Medical Advisory Secretariat
Ont Health Technol Assess Ser; 2007; 7(1):1-32. PubMed ID: 23074501
[TBL] [Abstract][Full Text] [Related]
6. Benefits and Harms of Breast Cancer Screening: A Systematic Review.
Myers ER; Moorman P; Gierisch JM; Havrilesky LJ; Grimm LJ; Ghate S; Davidson B; Mongtomery RC; Crowley MJ; McCrory DC; Kendrick A; Sanders GD
JAMA; 2015 Oct; 314(15):1615-34. PubMed ID: 26501537
[TBL] [Abstract][Full Text] [Related]
7. Tipping the balance of benefits and harms to favor screening mammography starting at age 40 years: a comparative modeling study of risk.
van Ravesteyn NT; Miglioretti DL; Stout NK; Lee SJ; Schechter CB; Buist DS; Huang H; Heijnsdijk EA; Trentham-Dietz A; Alagoz O; Near AM; Kerlikowske K; Nelson HD; Mandelblatt JS; de Koning HJ
Ann Intern Med; 2012 May; 156(9):609-17. PubMed ID: 22547470
[TBL] [Abstract][Full Text] [Related]
8. Breast Cancer Screening Strategies for Women With ATM, CHEK2, and PALB2 Pathogenic Variants: A Comparative Modeling Analysis.
Lowry KP; Geuzinge HA; Stout NK; Alagoz O; Hampton J; Kerlikowske K; de Koning HJ; Miglioretti DL; van Ravesteyn NT; Schechter C; Sprague BL; Tosteson ANA; Trentham-Dietz A; Weaver D; Yaffe MJ; Yeh JM; Couch FJ; Hu C; Kraft P; Polley EC; Mandelblatt JS; Kurian AW; Robson ME;
JAMA Oncol; 2022 Apr; 8(4):587-596. PubMed ID: 35175286
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of Breast Cancer Screening Strategies Based on Cancer Intervention and Surveillance Modeling Network Estimates.
Monticciolo DL; Hendrick RE; Helvie MA
Radiology; 2024 Feb; 310(2):e232658. PubMed ID: 38376405
[TBL] [Abstract][Full Text] [Related]
10. Comparison of recommendations for screening mammography using CISNET models.
Arleo EK; Hendrick RE; Helvie MA; Sickles EA
Cancer; 2017 Oct; 123(19):3673-3680. PubMed ID: 28832983
[TBL] [Abstract][Full Text] [Related]
11. A systematic assessment of benefits and risks to guide breast cancer screening decisions.
Pace LE; Keating NL
JAMA; 2014 Apr; 311(13):1327-35. PubMed ID: 24691608
[TBL] [Abstract][Full Text] [Related]
12. [Tailored Breast Screening Trial (TBST)].
Paci E; Mantellini P; Giorgi Rossi P; Falini P; Puliti D;
Epidemiol Prev; 2013; 37(4-5):317-27. PubMed ID: 24293498
[TBL] [Abstract][Full Text] [Related]
13. Clinical outcomes of modelling mammography screening strategies.
Yaffe MJ; Mittmann N; Lee P; Tosteson AN; Trentham-Dietz A; Alagoz O; Stout NK
Health Rep; 2015 Dec; 26(12):9-15. PubMed ID: 26676234
[TBL] [Abstract][Full Text] [Related]
14. Benefits and harms of annual, biennial, or triennial breast cancer mammography screening for women at average risk of breast cancer: a systematic review for the European Commission Initiative on Breast Cancer (ECIBC).
Canelo-Aybar C; Posso M; Montero N; Solà I; Saz-Parkinson Z; Duffy SW; Follmann M; Gräwingholt A; Giorgi Rossi P; Alonso-Coello P
Br J Cancer; 2022 Mar; 126(4):673-688. PubMed ID: 34837076
[TBL] [Abstract][Full Text] [Related]
15. Screening mammography in older women: a review.
Walter LC; Schonberg MA
JAMA; 2014 Apr; 311(13):1336-47. PubMed ID: 24691609
[TBL] [Abstract][Full Text] [Related]
16. Which strategies reduce breast cancer mortality most? Collaborative modeling of optimal screening, treatment, and obesity prevention.
Mandelblatt J; van Ravesteyn N; Schechter C; Chang Y; Huang AT; Near AM; de Koning H; Jemal A
Cancer; 2013 Jul; 119(14):2541-8. PubMed ID: 23625540
[TBL] [Abstract][Full Text] [Related]
17. Patient, primary care provider, and stakeholder perspectives on mammography screening frequency: lessons learned from a qualitative study.
Ro V; Jones T; Silverman T; McGuinness JE; Guzman A; Amenta J; Kukafka R; Crew KD
BMC Cancer; 2022 Jul; 22(1):819. PubMed ID: 35897000
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
